Literature DB >> 19066726

Expression of p75NTR in fetal brain and medulloblastomas: evidence of a precursor cell marker and its persistence in neoplasia.

Michael Barnes1, Charles G Eberhart, Rodney Collins, Tarik Tihan.   

Abstract

p75 neurotrophin receptor (p75NTR) is a member of the tumor necrosis factor superfamily, and plays a significant role in nervous system development. p75NTR has a dual (proliferative/apoptotic) role in neurogenesis and binds pro-neurotrophins with high affinity. Recent work suggests p75NTR is overexpressed in the developing cerebellum and in nodular/desmoplastic medulloblastomas. We analyzed p75NTR expression in various parts of the fetal and adult human central nervous system, and in 75 patients with medulloblastomas. The expression of p75NTR in the fetal brain was seen solely within the external granular layer with weaker expression in the Purkinje layer, which most likely represents Purkinje cell staining. The staining was present in gestational weeks 20-40, while no staining was identified elsewhere in the fetal brain or within the adult cerebellum. p75NTR positive cells were also positive with the proliferation marker ki-67, but were negative for ret, reelin, CD133, CD34, and cleaved caspase 3. Nine of 75 medulloblastomas (12%) were also showed positive immunostaining for p75NTR. The staining was seen in four classic, two desmoplastic, and three anaplastic medulloblastomas. The persistence of p75NTR in a small group of medulloblastomas raises the possibility that in such tumors, the receptor could be a potential therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066726     DOI: 10.1007/s11060-008-9755-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  25 in total

1.  Regional expression of p75NTR contributes to neurotrophin regulation of cerebellar patterning.

Authors:  Alexandre R Carter; Erin M Berry; Rosalind A Segal
Journal:  Mol Cell Neurosci       Date:  2003-01       Impact factor: 4.314

Review 2.  p75NTR--live or let die.

Authors:  Anders Nykjaer; Thomas E Willnow; Claus Munck Petersen
Journal:  Curr Opin Neurobiol       Date:  2005-02       Impact factor: 6.627

Review 3.  The p75 neurotrophin receptor in human development and disease.

Authors:  Nina Felice Schor
Journal:  Prog Neurobiol       Date:  2005-11-16       Impact factor: 11.685

Review 4.  Neurotrophin-regulated signalling pathways.

Authors:  Louis F Reichardt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

5.  beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.

Authors:  David W Ellison; Olabisi E Onilude; Janet C Lindsey; Meryl E Lusher; Claire L Weston; Roger E Taylor; Andrew D Pearson; Steven C Clifford
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

6.  TRK and p75 neurotrophin receptor systems in the developing human brain.

Authors:  E Y Chen; E J Mufson; J H Kordower
Journal:  J Comp Neurol       Date:  1996-06-10       Impact factor: 3.215

Review 7.  Neurotrophins in cerebellar granule cell development and medulloblastoma.

Authors:  S L Pomeroy; M E Sutton; L C Goumnerova; R A Segal
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

Review 8.  The many faces of p75NTR.

Authors:  Barbara L Hempstead
Journal:  Curr Opin Neurobiol       Date:  2002-06       Impact factor: 6.627

Review 9.  Medulloblastoma.

Authors:  C D Katsetos; P C Burger
Journal:  Semin Diagn Pathol       Date:  1994-05       Impact factor: 3.464

10.  Neural differentiation and maturation in metastatic medulloblastoma--case report.

Authors:  Y Kadota; H Arai; K Sato
Journal:  Neurol Med Chir (Tokyo)       Date:  1995-01       Impact factor: 1.742

View more
  9 in total

Review 1.  Neuronal Activity in Ontogeny and Oncology.

Authors:  Humsa Venkatesh; Michelle Monje
Journal:  Trends Cancer       Date:  2017-02-13

2.  Deconstruction of medulloblastoma cellular heterogeneity reveals differences between the most highly invasive and self-renewing phenotypes.

Authors:  Ludivine Coudière Morrison; Robyn McClelland; Christopher Aiken; Melissa Bridges; Lisa Liang; Xin Wang; Domenico Di Curzio; Marc R Del Bigio; Michael D Taylor; Tamra E Werbowetski-Ogilvie
Journal:  Neoplasia       Date:  2013-04       Impact factor: 5.715

3.  Novel gene expression model for outcome prediction in paediatric medulloblastoma.

Authors:  Magdalena Zakrzewska; Sylwia M Grešner; Krzysztof Zakrzewski; Beata Zalewska-Szewczyk; Pawel P Liberski
Journal:  J Mol Neurosci       Date:  2013-05-07       Impact factor: 3.444

4.  Clinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literature.

Authors:  Aurore Siegfried; Anne Isabelle Bertozzi; Franck Bourdeaut; Annick Sevely; Najat Loukh; Camille Grison; Catherine Miquel; Delphine Lafon; Nicolas Sevenet; Torsten Pietsch; Christelle Dufour; Marie-Bernadette Delisle
Journal:  Clin Neuropathol       Date:  2016 May-Jun       Impact factor: 1.368

5.  Valproic acid upregulates the expression of the p75NTR/sortilin receptor complex to induce neuronal apoptosis.

Authors:  Simona Dedoni; Luisa Marras; Maria C Olianas; Angela Ingianni; Pierluigi Onali
Journal:  Apoptosis       Date:  2020-10       Impact factor: 4.677

6.  WNT/β-catenin pathway activation in Myc immortalised cerebellar progenitor cells inhibits neuronal differentiation and generates tumours resembling medulloblastoma.

Authors:  H A Rogers; S Sousa; C Salto; E Arenas; B Coyle; R G Grundy
Journal:  Br J Cancer       Date:  2012-08-28       Impact factor: 7.640

7.  Cerebellar Purkinje cell p75 neurotrophin receptor and autistic behavior.

Authors:  L T Lotta; K Conrad; D Cory-Slechta; N F Schor
Journal:  Transl Psychiatry       Date:  2014-07-29       Impact factor: 6.222

8.  Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes.

Authors:  Lisa Liang; Christopher Aiken; Robyn McClelland; Ludivine Coudière Morrison; Nazanin Tatari; Marc Remke; Vijay Ramaswamy; Magimairajan Issaivanan; Timothy Ryken; Marc R Del Bigio; Michael D Taylor; Tamra E Werbowetski-Ogilvie
Journal:  Oncotarget       Date:  2015-11-17

9.  Maternal Subclinical Hypothyroidism in Rats Impairs Spatial Learning and Memory in Offspring by Disrupting Balance of the TrkA/p75NTR Signal Pathway.

Authors:  Fan Zhang; Xinyue Lin; Aihua Liu; Jian Chen; Zhongyan Shan; Weiping Teng; Xiaohui Yu
Journal:  Mol Neurobiol       Date:  2021-05-08       Impact factor: 5.590

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.